Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KNSA
KNSA logo

KNSA News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KNSA News

Kiniksa Pharmaceuticals International (KNSA.US) Officer Plans to Sell $3.14 Million in Common Stock via Form 144

May 01 2026moomoo

Enphase Energy Drops as Solar Demand Weakens

Apr 29 2026Fool

Kiniksa Pharmaceuticals Reports Strong Q1 Earnings, Shares Surge

Apr 29 2026Fool

Kiniksa Pharmaceuticals Reports Strong Sales Growth

Apr 29 2026NASDAQ.COM

Kiniksa Pharmaceuticals Q1 2026 Earnings Call Highlights

Apr 28 2026seekingalpha

Kiniksa Pharmaceuticals Exceeds Q1 Expectations and Raises Outlook

Apr 28 2026seekingalpha

Kiniksa Pharmaceuticals Q1 Earnings Exceed Expectations

Apr 28 2026seekingalpha

Kiniksa Reports Q1 2026: Significant Growth in ARCALYST Revenue

Apr 28 2026Newsfilter

KNSA Events

04/28 16:30
OpenAI Financial Concerns Weigh on Tech Stocks
The major averages closed broadly lower following a report highlighting weakness in OpenAI. Multiple tech stocks were slipping after the OpenAI report, which said CFO Sarah Friar told leadership she was concerned the ChatGPT maker may not be able to pay computing contracts in the future if it doesn't hit expansion goals quickly enough. The news comes amid a big week for corporate earnings, particularly with tech titans Alphabet, Amazon, Meta, Microsoft, and Apple set to report this week.Meanwhile, tensions between Washington and Tehran remain high as President Trump reportedly is unhappy with Iran's proposal to end the war. Such tensions, combined with the UAE announcing it will leave OPEC, impacted oil prices, which are back to hovering around the $100 per barrel mark.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:OpenAI has missed its internal targets for users and revenue,Coca-Colareportedand reiterated its FY26 revenue growth outlookUPSreportedand provided guidance for FY26 adjusted earnings growthGeneral Motorsprovided areport for Q1IACplans to change name toand said it will implement a workforce reduction2. WALL STREET CALLS:TFI Internationalto Buy at BofAOld Dominionto Neutral from Underperform at BairdTronoxto Sell at TruistRambusto Neutral at BairdDA DavidsonMicronat Buy on "longer-than-usual" memory cycle3. AROUND THE WEB:Appleis working on a major overhaul of the built-in photo-editing features for its iPhone, iPad, and Mac products, leaning heavily on AI, Bloomberg reportsAmetekis near a deal for Indicor's testing and measurement businesses, which would value them at around $5B, WSJ reportsMetais preparing to undo its acquisition of AI startup Manus after China banned the transaction, WSJ saysThe Federal Communications Commission is moving toward a review of Disney'sbroadcast licenses amid the Trump administration's fight with Jimmy Kimmel, Semafor reportsParamount Skydancefiled a petition to the Federal Communications Commission seeking permission for significant ownership by Middle East sovereign wealth funds, WSJ says4. MOVERS:Sanminagained afterand announcing the authorization of a $600M share buybackSolaris Energyincreased after, raising its guidance for Q2 and signing a third long-term power contractBridgeBioslipped after Pfizerenteredfor VyndamaxErascawas lower after disclosing aafter withdrawing from its Phase 1 trial for ERAS-0015Celesticafell in New York afterand providing guidance for Q25. EARNINGS/GUIDANCE:Ecolab, with EPS in-line with consensusKiniksareported Q1 results and raised its guidance for FY26S&P Global, with CEO Martina Cheung commenting, "We are pleased with the results we achieved in the first quarter"Operaand provided guidance for Q2 and FY26Asbury Automotive, with EPS and revenue missing consensusINDEXES:The Dow fell 25.86, or 0.053%, to 49,141.93, the Nasdaq lost 223.30, or 0.90%, to 24,663.80, and the S&P 500 declined 35.11, or 0.49%, to 7,138.80.

KNSA Monitor News

Kiniksa Pharmaceuticals Reports Strong Q1 2026 Earnings and Raises Guidance

Apr 28 2026

KNSA Earnings Analysis

No Data

No Data

People Also Watch